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ABSTRACT: This article critically analyses the prevalence, assessment and management of urinary tract 
infections (UTIs) in patients over the age of 65, in an urgent care out-of-hours service in order to enhance care. It
is undertaken from the perspective of working as an Advanced Nurse Practitioner (ANP). A synopsis of UTI is 
presented, examining the epidemiology and aetiology. The process of assessment, diagnosis and management 
of UTI in older people is appraised based on current evidence. Difficulties associated with the recognition of UTI 
in elderly are evaluated. Finally, recommendations are made for the improvement of future practice as an ANP.
MAIN TEXT
Urinary tract infections (UTIs) are among the most frequent bacterial infections seen within primary
care (National  Institute  for  Health and Care Excellence (NICE),  2020a).  They are caused by the
presence of  multiplying microorganisms in  the  urinary tract  with  infection  being  determined by  a
combination of bacteria in the urine plus clinical features (NICE, 2015). It is estimated that over 92
million people are affected worldwide and among older people, UTI is a substantial cause of mortality
(NIHR Community Healthcare Medtech and In Vitro Diagnostics Cooperative, 2016). It is estimated
that 1-3% of primary care attendances are due to UTI-related symptoms and they comprise the main
reason  for  13.7%  of  antibiotic  prescribing  (NIHR  Community  Healthcare  Medtech  and  In  Vitro
Diagnostics  Cooperative,  2016).  The  prevalence  is  approximately  20% in  women  aged over  65,
compared with 11% in the overall population (Chu and Lowder, 2018). However, both genders are at
risk of UTI in older age, with a male-to-female ratio of 1:2 (Cove-Smith and Almond, 2007). The risk
increases substantially in patients over the age of 85 (Rowe and Manusga, 2014).
Definitions and wider context
UTI is defined as an infection of the urinary system, involving lower tract, upper tract or both (NICE,
2020a). The pathogens responsible for UTI include Escherichia coli (E. coli) which account for 70% to
95% of uncomplicated cases, with  Staphylococcus saprophyticus responsible of 5% to 20% of cases
(NICE, 2019).  Less common pathogens in uncomplicated UTIs include  Proteus mirabilis,  Klebsiella
species, Citrobacter genus, Pseudomonas aeruginosa, group B streptococci and enterococci (BMJ Best
Practice (2020). UTI generally occur  when uropathogens found in faecal flora contaminate the peri-
urethral area; these then ascend into the bladder via the urethra causing a lower UTI. Uropathogens
may migrate further from the bladder into the kidneys, via the ureters, resulting in pyelonephritis, an
upper UTI (BMJ Best Practice (2020).
Bacteria present in the urine is known as bacteriuria, and the occurrence of bacteria in the urine
without signs and symptoms of a UTI is defined as asymptomatic bacteriuria (Ninan et al, 2014). The
prevalence of asymptomatic bacteriuria is high in older people, especially those living in long-term
care, making diagnosis and treatment difficult because it does not essentially signify acute infection,
and in isolation it is not an indication for antibiotics (Nicolle et al, 2005). These diagnostic challenges
may lead to over-diagnosis, excessive antibiotic treatment and delay in making accurate diagnoses
(Ninan et al, 2014)
Antibiotic prescribing
UTI  is  the  second  most  frequent  reason  for  the  prescription  of  antibiotics  within  primary  and
secondary care, with over 50% of prescriptions in older adults believed to be  unnecessary (Public
Health England (PHE), 2020). Over-treatment can lead to adverse reactions from antibiotics, and with
ever  increasing  antimicrobial-resistance  (AMR)  antibiotic  reduction  in  this  age  group  is  essential
(Mayne et al, 2019). AMR is a growing threat to public health; antimicrobial stewardship and national
guidelines are aimed at  opposing these challenges and must be adhered to in practice (Scottish
Intercollegiate Guidelines Network (SIGN), 2012; NICE, 2018d; 2020a; 2020b; PHE, 2020b). 
Urosepsis
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E. coli can enter the bloodstream following a UTI, manifesting as urosepsis, with E. coli bacteraemia
being the most common cause of sepsis in the UK (Thornton et al 2018). Urosepsis is increasing each
year  with  studies  revealing  that  only  18%  of  cases  are  hospital-based  onset  (PHE,  2020a). In
England, 43,294  E. coli bacteraemia cases were reported in 2019/20,  with 6,005 deaths reported
(PHE, 2021). With  no definite cause highlighted, it has been  suggested that it could be related to
delayed treatment of UTI in primary care, and antimicrobial stewardship initiatives (Thornton et al,
2018). 
However, increasing incidence of older people with frailty and increasing resistance could explain
the growing morbidity associated with UTIs (Allison and McNulty, 2019). Cases of E. coli bacteraemia
increased by 35% over 2013–2017, with the highest rates in England noted among older people, with
significant  risk  factors  including  recurrent  UTIs,  frequent  antibiotic  use  and  indwelling  catheters
(Abernethy et al,  2016).  This  presents challenges to working as an autonomous advanced nurse
practitioner (ANP) in out-of-hours (OOH) care. The burden of UTI in older people is anticipated to
grow due to an increase in the ageing population, in addition there are wide variations in presenting
symptoms and management of UTI, with overall adherence to guidance varying between services
(Philips et  al,  2014).  It  is  therefore essential  to  improve diagnostic,  management  and prevention
approaches to enhance the health outcomes of older adults (Gharbi et al, 2019).
ANP roles
There is an increasing prevalence of ANP roles throughout the urgent care OOH service, including
urgent care centres, walk-in centres, on-day home visiting services and urgent care home visiting.
ANPs are well positioned to have crucial roles in the assessment and management of UTIs in patients
aged over 65. In this age group, NICE stipulates that a full clinical assessment and examination is
required prior to formulating a working diagnosis of UTI (NICE, 2015), including the completion of vital
signs (SIGN, 2012). This is due to the complexity of assessment in older patients; various indicators
can affect assessment and restrict the ability to assess for acute symptoms. For example, cognitive
impairment may reduce the ability to communicate or give a history about symptoms and coexisting
illnesses that present with nonspecific symptoms such as urinary incontinence (Ninan et al, 2014). 
The clinical decision-making processes in urgent care OOH depends on quickly assessing whether
a  patient  is  presenting  with  an  infection  or  displaying  signs  of  sepsis  or  deterioration.  ANP
development  requires  acquisition of  comprehensive assessment  skills  (Health  Education England
(HEE), 2017). It is crucial as an ANP to have the ability to assimilate information, formulate decisions
and apply these decisions correctly into practice (HEE, 2017). Working within the HEE framework for
Advanced  Clinical  Practice  (HEE,  2017)  it  is  vital  to  holistically  assess  patients,  incorporating  a
comprehensive history and identifying risk factors. 
To help obtain a clinical  picture it  is  essential  that  a full  and thorough history is taken  (NICE,
2020a).  If  patients  have  reduced ability  to  give  an exact  history,  clinical  staff,  carers,  friends  or
relatives are asked whether cognitive decline, functional or behavioural changes are new, ongoing or
acute (NICE, 2020a). 
Considerations in assessment and management
Symptoms of UTI
Symptoms  of  UTI  include  dysuria,  urgency,  urinary  frequency,  changes  to  urine  consistency  or
appearance, nocturia and suprapubic pain (NICE, 2020a). However, in older patients these features
may not be present, also patients with UTI generally present with non-specific clinical features such
as increased confusion or delirium, lethargy, reduced appetite, incontinence, reduced mobility or the
inability to carry out normal activities of daily living (NICE, 2020a). Pyrexia, renal angle pain, loin pain,
vomiting or rigors can indicate pyelonephritis (NICE, 2020a, 2020b). If undiagnosed, this can progress
adversely to sepsis and renal failure (Kalra and Raizada, 2009).  Importantly, it  is  essential  to be
aware that older patients are vulnerable and may have impaired immunity, therefore a low threshold
for sepsis is assumed when a patient shows signs of UTI, plus acute disease (NICE, 2017; UK Sepsis
Trust, 2019). 
National Early Warning Score
To  assist  in  the  detection  of  deterioration  in  adult  patients  the  National  Early  Warning  Score  2
(NEWS2)  tool  is  used  (Royal  College  of  Physicians  (RCP),  2017).  NEWS2  comprises  the
physiological readings of patients including systolic blood pressure, heart rate, temperature, oxygen
saturation respiratory rate, and consciousness level, with adjusted scoring when there is a need for
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oxygen therapy (RCP, 2017). The values are measured, recognising that patients with a high score
are more at risk of deterioration (RCP, 2017). For patients with a NEWS2 score of five or more, the
local sepsis protocol is adhered to and a 999 transfer to secondary care is  made (NHS England,
2017).  
PHE (2019) indicates that UTI is likely in patients above 65 years that have new onset dysuria with
two or more of the following: new urgency or frequency, new incontinence, new or worsening delirium,
new suprapubic pain, visible haematuria or an increased temperature 1.5°C higher than the patient’s
normal temperature. However, if fever and delirium or debility are present, other sources of infection
and causes of delirium other than UTI must be excluded before making a diagnosis of UTI (NICE,
2020a; PHE, 2020b). Other sources of infection may include respiratory, gastrointestinal, skin and soft
tissue, and should be investigated and treated in line with local guidance (PHE, 2020b).
Delirium
A systematic review analysed the association between UTI and delirium and found that in patients
without a UTI, delirium rates were 7.7% to 8% compared with patients who had a confirmed UTI,
where delirium rates were 30% to 35% (Balogun and Philbrick, 2014). However, with methodological
flaws and bias being noted, more research is needed in this area  (Balogun and Philbrick, 2014).
Nevertheless, it is practical to accept the association between symptomatic UTI and delirium just as it
is  with delirium and numerous other conditions and infections (Balogun and Philbrick, 2014). It  is
noted  that  the  presence  of  asymptomatic  bacteriuria,  without  frequency,  dysuria,  pyrexia  or
suprapubic  discomfort,  is  a  doubtful  cause  of  delirium,  and other  contributing factors  are  always
considered and investigated (Gau et al, 2009). 
For  the  assessment  of  delirium  or  new confusion,  PHE (2020b)  recommends  the  use  of  the
mnemonic  PINCH  ME,  which  stands  for:  pain,  other  infection,  reduced  nutrition,  constipation,
hydration, medications and environmental changes. This is applied in practice when assessing older
patients and is a useful tool for the review of possible causes for delirium. Another tool used for the
rapid assessment of delirium is the Arousal, Attention, Abbreviated Mental Test 4, Acute change tool
(4AT) (MacLullich, et al, 2011). It is quick to apply in practice with high sensitivity and no training is
required for its use (Healthcare Improvement Scotland, 2019). With patients that have no new signs of
UTI,  when  other  infections  have  been  ruled  out,  PHE  (2019)  advice  that  ‘watchful  waiting’  is
employed, whilst investigations for further causes are completed. 
Patients with symptoms of a UTI who have a urinary catheter in situ are checked for signs of
blockage  and  removal  or  replacement  is  considered  (NICE,  2019;  PHE,  2019).  Competing
differentials are considered during assessment including, urethritis, prostatitis, vulvovaginal atrophy or
genitourinary syndrome of menopause, and sexually transmitted diseases, as all of these can cause
symptoms of UTI (Portman and Gass, 2014; Michaels and Sands 2015).
Urinalysis
For the diagnosis of patients over the age of 65 the use of urine dipsticks is not recommended (PHE,
2020b). Most patients with catheters and half of older patients will have asymptomatic bacteriuria in
the  bladder  without  infection  (PHE,  2020b).  Although asymptomatic  bacteriuria  is  not  harmful  to
patients it will create a positive dipstick reaction, thereby  misleading the  results (PHE, 2020b).  The
diagnosis of asymptomatic bacteriuria without UTI symptoms is made by a midstream urine sample
indicating bacterial growth greater than 10⁵ colony-forming units per millilitre (cfu/ml) in one single
sample in men and two consecutive samples in women (Bonkat et al, 2019). 
Diagnosis  of  UTI  in  all  patients  over  the age of  65 is  based on taking a full  history  including
associated  symptoms,  previous  episodes  of  UTI,  risk  factors,  past  medical  history,  prescribed
medications,  previous  antibiotics  and  a  full  examination  including  vital  signs  and  abdominal
examination (SIGN, 2012; NICE, 2019). Change to urine colour or smell is also not a diagnostic tool
but may be specifically related to dehydration, so a history of fluid intake is essential (Ninan et al,
2014). If either non-visible or visible haematuria continues following treatment of a UTI, it requires
further investigation to rule out the cause, with referral to secondary care as required (NICE, 2017). 
Midstream specimen of urine
To confirm a diagnosis and guide antibiotic prescribing a midstream specimen of urine (MSU) must be
sent for culture and sensitivity in patients over the age of 65 (PHE, 2020b).This diagnostic certainty is
not always possible working within OOH urgent care, where there is no facility to send MSU samples
for pathology, and delays in sending are unavoidable, however the a boric acid preservative may be
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used or refrigeration at 4°C is suggested and the sample can then be sent the following day (PHE,
2019).  Difficulties arise when collecting an MSU from older  people due to incontinence, and it  is
recommended to only take an MSU if a patient is symptomatic and capable of collecting a satisfactory
sample  (PHE,  2019).  A  clean  catch  in  a  disinfected  container  and  for  men the  use  of  condom
catheters may be feasible options for incontinent patients but there is poor evidence to support these
techniques (Latour et al, 2013). MSU samples from patients with indwelling catheters should be taken
from a newly inserted catheter using an aseptic technique (PHE, 2019). 
It is recognised that within the guidance the diagnosis and management of UTI in older people uses
the age of 65 years as a cut off (SIGN, 2012; PHE, 2020b), however in practice it is evident that this is
not  a standardised group and may include self-caring, fit  and healthy older women, who may be
managed similarly to those aged under 65 years, and they are assessed on an individual basis, to
allow for patient-centered care (HEE, 2017). However, in males, management does not change and
an MSU is always required (NICE, 2020b).
Culture results are interpreted alongside the severity of signs and symptoms that patients present
with because false negatives can occur (PHE, 2020b). In patients that present with urinary symptoms,
urine culture results may indicate a UTI if there is a growth of 10⁴-10⁵ cfu/ml, whereas in results that
have a mixed growth or epithelial cells a retest may be required if symptomatic (PHE, 2020b). 
Antibiotic choice
Best practice for the treatment of a lower UTI is to send an MSU prior to antimicrobial prescribing so
that results can be tailored to sensitivities. However, this is only possible if the patient is systemically
well, not considered high risk and it is deemed safe to wait for treatment. In an OOH setting, this is
challenging, and safety of patients is paramount (HEE, 2017). If  antibiotics are required, previous
sensitivity,  resistant  patterns and previous treatments must be  noted (NICE, 2018d),  with narrow
spectrum antibiotics prescribed where possible, to minimise the chance of clostridium difficile and
AMR.  In  E. coli urine  isolates  28.6% are  resistance  to  trimethoprim,  in  comparison  nitrofurantoin
resistance is 2%, and pivmecillinam 6% within England (PHE, 2020b). 
Nitrofurantoin is consequently the first-line antibiotic to consider in all  patients (NICE and PHE,
2020). In patients with reduced renal function nitrofurantoin achieves low urinary concentration and if
an  estimated  glomerular  filtration  rate  (eGFR)  is  below  45 ml/minute  other  antibiotics  must  be
considered (Joint Formulary Committee, 2021)  including trimethoprim, pivmecillinam, or fosfomycin
(NICE and PHE, 2020). The recommended treatment length for a lower UTI is 3 days for women and
7 days for men (NICE and PHE, 2020). There is good evidence to support the use of 3 days in women
where a meta-analysis of 1644 older women proved that 3 to 6 days of antibiotics was comparable
with 7 to 14 days, with no differences in patient satisfaction, re-infection rates, symptom duration or
adverse events (Lutters et  al,  2008).  However,  there is a poor amount of  evidence in relation to
antibiotic duration in older men and 7-day treatment is principally founded on expert consensus within
national guidelines (SIGN, 2012; PHE, 2018d; Bonkat et al, 2019).
For  the management  of  pyelonephritis  referral  must  be considered  if  patients  present  as  very
unwell, with signs of sepsis, dehydration, are not taking fluids, have an increased risk of acquiring
complications including structural or functional defect of the genitourinary tract, immunosuppression or
diabetes mellitus (NICE, 2020b). For patients who are well and can be managed within primary care,
latest  guidance  recommends  cefalexin  as  first  line  treatment  for  7–10  days,  as  it  has  a  lower
resistance than co-amoxiclav and ciprofloxacin, with randomised controlled trials demonstrating that it
is similarly effective (NICE, 2018). 
For patients with an indwelling catheter and new signs of symptoms of a UTI, this should be treated
with antibiotics and a catheter change if over 7 days old (NICE, 2018b) . Antibiotic treatment and
management remain as per guidance as associated symptoms of lower UTI or pyelonephritis (NICE,
2018a, 2018d). However, in patients without new symptoms and who are well, treatment should not
be commenced without MSU results (NICE, 2018b).
Communication
Communication is vital to the role of the ANP with verbal and written information given to the patient
or  their  carer  during the consultation,  this includes actions to  be taken if  their  condition fails  to
improve, changes or if they have further concerns about their health to aid the safe management of
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patients (HEE, 2017). Advice is provided regarding diagnosis and treatment, self-care including fluids
and paracetamol, clear instructions regarding worsening symptoms or ongoing symptoms that are not
improving within 48 hours of treatment and details of who they need to contact to access further care
(NICE,  2018a).  Patients’  or  carers’  levels  of  understanding  concerning  safety  netting  advice  are
assessed, and related referrals are made as a duty of care for observational reasons (Nursing and
Midwifery Council, 2018). Written advice is available from the Royal College of General Practitioners
TARGET antibiotics  toolkit  website  (https://www.rcgp.org.uk/TARGETantibiotics)  regarding  UTI  for
older  adults  and  carers  and  is  used  in  practice  to  allow  for  education  regarding  self-care  and
understanding  of  safety  netting  advice  (PHE,  2018;
https://www.rcgp.org.uk/clinical-and-research/resources/toolkits/amr/target-antibiotics-toolkit/leaflets-
to-share-with-patients.aspx ).  
Recognition of UTI in elderly patients is not always straightforward. Older women can exhibit signs
of  a  UTI  as  a  consequence  of  oestrogen  deficiency  and  evidence  supports  the  use  of  vaginal
oestrogen cream or pessaries to reduce the risk of re-occurring UTI diagnosis (Perrotta et al, 2008).
Elderly patients may have existing medical conditions such as benign prostatic hyperplasia disease,
dementia and constipation that may predispose them to incontinence and UTIs (SIGN, 2012; NICE,
2012).  A  full  history  of  patients’  prescribed  medications  is  essential,  since  drugs  such  as
antimuscarinics also may predispose patients to symptoms of UTI, as they are known to cross the
blood–brain barrier, and may cause confusion, reduce bladder emptying and trigger or exacerbate
constipation (NICE, 2012).
National guidance
Previous national guidance regarding UTI was not specifically aimed at patients over the age of 65,
however, the latest guidance includes diagnostic flow charts for this age  group (PHE, 2020b)  and
should be used in practice. This will aid diagnosis and treatment with potential to allow for improved
prescribing alongside antimicrobial stewardship and result in improved outcomes for patients. Working
as an ANP it is important to understand the necessity for changes to healthcare policy and guidance
and to use leadership skills to influence junior staff and other members of the multidisciplinary team to
promote best practice (Anderson, 2018).
Conclusion
The  correct  management  of  elderly  patients  who  are  seen  within  OOH urgent  care  with  UTI  is
challenging for ANPs since the signs and symptoms might vary widely (PHE, 2020b).  With a broad
variation in practice, interpretation of symptoms, diagnostic tests, and commencement of antibiotic
treatment, the diagnosis of UTI is extremely difficult in older patients, especially as they may have
asymptomatic  bacteriuria  (Butler  et  al,  2015).  To  prevent  variation  in  practice  and  unnecessary
treatment, latest evidence-based guidance should be adhered to, with outdated practices such as
urine dipstick tests only being used where guided, to reduce unwarranted antibiotics and reduce the
emergence  of  AMR in  the  community.  ANPs  should  educate  patients  about  self-care  measures
regarding hydration, catheter and incontinence care to prevent re-occurring symptoms (PHE, 2019).
Crucial  knowledge regarding  the  signs  and symptoms,  assessment  and management  of  patients
presenting with symptoms of UTI allows patients to be safely managed, which is pertinent to the role
of the advanced practitioner (HEE, 2017). Ensuring high-quality, safe, patient-centred care requires
excellent communication skills, as well as education of staff and MDT, patients and relatives. 
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